Glenmark Pharma Q3 results: Standalone loss at Rs 20 cr, revenue dips 38.4%
Glenmark is going through a transitionary phase on account of divestment of Glenmark Life Sciences, says MD
from Latest News https://ift.tt/k6oaDld
via WebMD https://bsmedia.business-standard.com/_media/bs/img/article/2019-08/14/thumb/1565801938-3166.jpg
ABOUT THE AUTHOR
Hello We are OddThemes, Our name came from the fact that we are UNIQUE. We specialize in designing premium looking fully customizable highly responsive blogger templates. We at OddThemes do carry a philosophy that: Nothing Is Impossible
